Sionna Therapeutics, Inc.
Company Stats
- Market Cap
- $237.8M
- as of Sep 30, 2026
- Shares Outstanding
- 45.2M
- Free Float
- 28.1%
Income Statement
- Operating Income
- -$89.0M
- Net Income
- -$75.3M
- EBITDA
- -$88.3M
Cash Flow
- Free Cash Flow
- -$66.7M
- FCF Yield
- -28.0%
- Owner FCF Yield
- -33.1%
Balance Sheet
- Cash & Equivalents
- $58.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$66.7M | — |
| FY2024 | — | -$52.8M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges